To establish that recovery time from a bronchoprofocation test is faster with HFNC compared to no interfention
ID
Source
Brief title
Condition
- Bronchial disorders (excl neoplasms)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Recovery time after bronchoprovocation test, measured using spirometry.
Secondary outcome
1. Recovery time after the bronchoprovocationtest, measured using diaphragmatic
EMG
2. The relation between the pressures that the HFNC device produces to create
the applied flow and the recovery of lungfunction after the brochoprovocation
test
3. The relation between the shape of scaled tidal flow-volume curves and the
recovery of lungfunction after the brochoprovocation test.
Background summary
To establish wether a frequently used form of ariway therapy (HFNC) is suitable
for childhood asthma
Study objective
To establish that recovery time from a bronchoprofocation test is faster with
HFNC compared to no interfention
Study design
a randomized prospective cross-over trial
Intervention
High Flow Nasal Cannula therapy
Study burden and risks
The burden for the participants is an extra hospital visit with one additional
bronchoprovocation test. The risk of this extra test is negligable.
Koningsplein 1
Enschede 7512KZ
NL
Koningsplein 1
Enschede 7512KZ
NL
Listed location countries
Age
Inclusion criteria
lungfunction liability >30% after bronchoprovocation test
Exclusion criteria
unable to perform spirometry
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
| Register | ID |
|---|---|
| CCMO | NL75416.100.20 |
| OMON | NL-OMON20724 |